Tolterodine

Drug Profile

Tolterodine

Alternative Names: Detrol; Detrol LA; Detrusitol; Detrusitol SR; Detrusitol XL; KABI 2234; PNU 200583E; Tolterodine tartrate; Urotrol

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pfizer
  • Developer Allergan; Almirall S.A.; Laboratorios Funk; Pfizer
  • Class Antispasmodics; Benzhydryl compounds; Cresols; Small molecules
  • Mechanism of Action Muscarinic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Overactive bladder

Most Recent Events

  • 01 Jul 2014 Forest Laboratories has been acquired by Actavis Inc
  • 30 May 2013 Biomarkers information updated
  • 01 Jan 2013 Phase-II clinical trials in Nocturia (combination therapy) in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top